KIMS to Set Up 300-Bed Super Speciality Hospital in Chennai for ₹300 Crore
Krishna Institute of Medical Sciences Limited (KIMS) will establish a new 300-bed Super Speciality Hospital in Chennai, Tamil Nadu. The project involves leasing 1.168 acres of land and an investment of approximately ₹300 Crore. The expansion is expected to be completed within 36 months and will be financed through bank loans and internal accruals.
The establishment of a new 300-bed hospital represents a notable capacity addition and investment for KIMS, which could impact its market presence and financial performance, though the full impact will be realized over the 36-month development period.
The announcement details a significant strategic expansion for KIMS, marking its entry into a new state (Tamil Nadu) with a substantial new hospital project, which is expected to drive future growth and financial returns.
Krishna Institute of Medical Sciences Limited (KIMS) has entered into a Leave and License Agreement with Andhra Mahila Sabha to lease approximately 1.168 acres of land in Chennai, Tamil Nadu. This land, located at Dr. Durgabai Deshmukh Road, Raja Annamalai Puram, will be used to establish a new Super Speciality Hospital.
The proposed hospital will add approximately 300 beds to KIMS's existing capacity. The company plans to complete this expansion within the next thirty-six (36) months. The total investment required for this project is estimated to be around ₹300 Crore, which will be financed through a combination of bank loans and internal accruals.
This strategic expansion marks KIMS's first venture into Tamil Nadu and is expected to enhance operational performance and generate sustainable long-term financial returns. As of September 30, 2025, KIMS and its subsidiaries had a total bed capacity of over 8800 beds, with an occupancy rate of approximately 51.0% for H1FY26.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.